Anzeige
Meldung des Tages: Drohnenangriffe schockieren die Welt – dieser Tech-Player will die Verteidigung neu definieren

LakeShore Biopharma News

Aktie
WKN:  A40P1H ISIN:  KYG9845F2080 US-Symbol:  LSBCF Branche:  Biotechnologie Land:  China
0,05 $
-0,018 $
-26,47%
0,04317 € 04.03.26
Depot/Watchlist
Marktkapitalisierung *
-
Streubesitz
100,00%
KGV
-
Index-Zuordnung
-

LakeShore Biopharma News

06.02.26 - PR Newswire
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders
LakeShore Biopharma Announces Receipt of Buyer Group Notice and Postponement of Extraordinary General Meeting of Shareholders PR Newswire
20.01.26 - PR Newswire
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders PR Newswire
04.11.25 - PR Newswire
LakeShore Biopharma Enters into Definitive Agreement for Going-Private Transaction
LakeShore Biopharma Enters into Definitive Agreement for Going-​Private Transaction PR Newswire
22.09.25 - PR Newswire
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting PR Newswire
12.09.25 - PR Newswire
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq
LakeShore Biopharma Announces Receipt of Delisting Determination Letter from Nasdaq PR Newswire
10.09.25 - PR Newswire
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
LakeShore Biopharma Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee PR Newswire
28.08.25 - PR Newswire
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
LakeShore Biopharma Announces Receipt of a Revised Preliminary Non-​Binding Proposal to Acquire the Company and Formation of Special Committee PR Newswire
18.08.25 - PR Newswire
LakeShore Biopharma Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company
LakeShore Biopharma Announces Receipt of a Preliminary Non-​Binding Proposal to Acquire the Company PR Newswire
31.07.25 - PR Newswire
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results
LakeShore Biopharma Announces Fiscal Year 2025 Financial Results PR Newswire
08.07.25 - PR Newswire
LakeShore Biopharma Announces US$15 Million Private Placement Financing
LakeShore Biopharma Announces US$15 Million Private Placement Financing PR Newswire
23.04.25 - PR Newswire
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell)
LakeShore Biopharma Announces the Official Launch of a Novel Packaging Solution for YSJA™ Rabies Vaccine (Vero Cell) PR Newswire
19.12.24 - PR Newswire
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance
LakeShore Biopharma Reports Unaudited Financial Results for the First Half of Fiscal Year 2025 and Updates Full-Year Guidance PR Newswire
29.10.24 - PR Newswire
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement PR Newswire
25.10.24 - PR Newswire
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine PR Newswire
08.10.24 - PR Newswire
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance
LakeShore Biopharma Provides Fiscal Half Year 2025 Financial Guidance and Reaffirms Fiscal Year 2025 Financial Guidance PR Newswire
27.09.24 - PR Newswire
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation
LakeShore Biopharma Announces Results of Extraordinary General Meeting on Share Consolidation PR Newswire
10.09.24 - PR Newswire
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 PR Newswire
04.09.24 - PR Newswire
LakeShore Biopharma Announces Leadership Transitions
LakeShore Biopharma Announces Leadership Transitions PR Newswire
15.08.24 - PR Newswire
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 PR Newswire
05.07.24 - PR Newswire
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition
LakeShore Biopharma to Hold an Extraordinary General Meeting on July 25, 2024, Pursuant to Shareholders' Requisition PR Newswire

Newssuche

Videos

newspaper
04.03.26 +3,01%
ROHÖL mit Ziel MINUS 40$?!?
Fundierte Strategien für den Handel der wichtigen News in einem Seminarpaket, plus transparenter ... Mehr »